Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lacosamide for treatment-resistant bipolar disorder
jRCTs041180033Completed
- Sponsor
- Fujita Health University Hospital
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of lacosamide in bipolar disorder (BD), sponsored by Fujita Health University Hospital. Primary endpoint: Clinical Global Impression-Severity. Started Apr 2018; status: completed.
02
Drugs
lacosamide
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on jRCTs041180033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041180033.